In 2016, media coverage of artificial cannabinoid use and linked hospitalizations engendered unconstructive hysteria. Experiences on the drug’s presence in Brooklyn referred to those who use “K2” as zombies, and emphasized the spike in hospitalizations, all with little dialogue in